Developer docs
API playgroundTry for free, no card

Search company profiles

VETS, Veterans Exploring Treatment Solutions

Full company profile

uuid000ohe8

Namestring
VETS, Veterans Exploring Treatment Solutions
Legal namestring
VETS, Inc.
Company typeenum
Private
Founded yearint
2019
Descriptiontext

VETS (Veterans Exploring Treatment Solutions) is a 501(c)(3) nonprofit founded in 2019 and headquartered in Coronado, California, that facilitates U.S. veteran access to psychedelic-assisted therapies for PTSD, traumatic brain injury, and other service-related conditions. Its core product is the Foundational Healing Grant program, which directly funds veterans to receive treatment at approved international and domestic clinics — by 2025, the program had supported 1,300+ veterans and spouses with 1,200+ grants awarded across 16 states, accompanied by longitudinal wellbeing assessments (350+ data points) used to build an outcomes evidence base.

The organization operates through three program pillars: Resources (grants, an E-Course, and a Foundational Healing Workbook), Research (clinical study partnerships with Stanford — including a Nature Medicine publication on MDMA-assisted therapy — and Ohio State), and Advocacy (federal and state policy work). Strategic research partnerships with major academic medical centers, alongside direct policy engagement, have helped VETS contribute to securing over $124M in public research funding, including a Texas $100M Ibogaine Initiative, California AB 1103, and a White House executive order on ibogaine research. The VALOR Coalition, launched in 2025 with major Veterans Service Organizations, extends this convening role.

VETS is funded through philanthropic donations rather than commercial revenue. In 2025, total fundraising was approximately $6.7M, drawn from individual donors (~$3.3M), foundations (~$1.99M), events (~$737K), and corporate giving (~$681K). The organization holds a 4-star Charity Navigator rating, has received Emmy nominations for the Netflix documentary "In Waves and War" (premiered November 2025), and reports a 100% veteran recommendation rate. Go-to-market is primarily community and VSO-driven rather than paid acquisition, and brand visibility has been materially elevated by media coverage and policy wins during 2025–2026.

Short descriptiontext

VETS (Veterans Exploring Treatment Solutions) is a 501(c)(3) nonprofit founded in 2019 that funds U.S. veterans' access to psychedelic-assisted therapies through grants, research partnerships with Stanford and Ohio State, and veteran-focused policy advocacy.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSan Diego, United States
HQ citystring
San Diego
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
veteran mental health services, psychedelic-assisted therapy, nonprofit advocacy, veteran suicide prevention, military mental health
Industry1 code
1Behavioral Health & Substance Use Program Funding (Public Health)
CodeHLAJALAIPrimaryYes
NAICS code2 codes
  • Voluntary Health Organizations813212
  • Other Grantmaking and Giving Services813219
Product category
Veteran Mental Health Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model5 records
1Individual Donations
TypeGrants Donations
Description

Individual donors contribute to VETS' mission, including major donors, recurring donors, and event attendees. In 2025, individuals contributed $3.3M out of total income of $6.7M.

vetsolutions.org
2Foundation Grants
TypeSubscription Recurring
Description

Foundation funding supports research, advocacy, and program operations. In 2025, foundations contributed $1.99M.

vetsolutions.org
3Corporate Partnerships
TypeSubscription Recurring
Description

Corporate sponsors support VETS events and programs, including Black Rifle Coffee Company, Ambio Life Sciences, Dr. Bronner's, and others. In 2025, corporations contributed $681K.

vetsolutions.org
4Events
TypeProfessional Services
Description

The annual Torchbearer Ball and other fundraising events generate revenue. The 2025 Torchbearer Ball raised over $1.4 million.

vetsolutions.org
5Merchandise Sales
TypeHardware Sales
Description

VETS operates an online store selling merchandise including the Foundational Healing Workbook and branded items.

vetsolutions.org
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Operations, Personnel, Marketing or Sales, Technology or R&D, Others
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

VETS provides grant funding and wraparound support to help U.S. military veterans and their spouses access psychedelic-assisted therapies (ibogaine, ketamine, psilocybin, MDMA, 5-MeO-DMT) at vetted third-party international facilities, where these treatments are legal or unregulated. The organization supplements grant funding with preparation and integration coaching, meditation, yoga, and community resources. VETS also funds research (Stanford, Ohio State, UCSF) and drives policy advocacy (Texas Ibogaine Initiative, California AB 1103, federal executive orders) to expand domestic access.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 93.2% of polled VETS grant recipients feel less depressed after treatment
+4 more records
Product overview1 text field

VETS (Veterans Exploring Treatment Solutions) is a 501(c)(3) nonprofit organization offering a holistic ecosystem of programs supporting veterans' access to psychedelic-assisted therapies. The core offering is the Foundational Healing Grants program, which provides funding and wraparound support for veterans to access treatments including ibogaine, ketamine, psilocybin, MDMA, and 5-MeO-DMT at international facilities. This is supplemented by the free VETS E-Course for education, the VETS Community Platform for ongoing integration support, the VETS Foundational Healing Workbook for preparation, and Meditation and Breathing Exercises for wellness. The organization also produces advocacy content including the Netflix documentary 'In Waves and War' and hosts the annual Torchbearer Ball fundraising event. All services are designed to address the veteran suicide epidemic through three pillars: resources (direct support), research (scientific validation), and advocacy (policy change).

Product and service2 records
1Foundational Healing Grants
CategoryGrant program / core service
Description

Grant program that funds U.S. military veterans and their spouses to access psychedelic-assisted therapies (ibogaine, ketamine, psilocybin, MDMA, 5-MeO-DMT) at vetted international facilities, paired with preparation and integration coaching, meditation, yoga, and community resources.

2VETS Foundational Healing Workbook
Scale indicator22 records

Each record includes

Type, Value, Description, Source

Partnership16 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-01-05
Description

VETS collaborated with Stanford Brain Stimulation Lab led by Dr. Nolan Williams on a groundbreaking Nature Medicine study examining ibogaine therapy effects on veterans with TBI and PTSD. The study enrolled 30 U.S. Special Operations veterans, all supported by VETS through Foundational Healing Grants. Results showed dramatic improvements including reduced suicidal ideation from 47% to 7%.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-01-05
Description

All study participants received treatment at Ambio Life Sciences, an independent clinic in Mexico providing somatic therapies alongside psychedelic therapies in a medically supported environment. VETS provided travel funding as part of its grants program.

Strategic tierMinorTypeOthersAnnounced on2024-01-05
Description

Jonathan Dickinson, CEO of Ambio Life Sciences, provided statement reinforcing the safety and efficacy findings from the Stanford study and highlighting ibogaine's healing potential.

4Ohio State University Center for Psychedelic Drug Research and Education (CPDRE)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Dr. Alan Davis leads a program evaluation of VETS grant recipients - the largest longitudinal observational study of psychedelic treatment in U.S. veterans with over 130 participants enrolled. Five peer-reviewed publications are in development. The study follows Dr. Davis' 2019 retrospective study of veterans receiving ibogaine therapy.

vetsolutions.org
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Formal collaboration with UCSF's Translational Psychedelic Research Program on wellbeing assessments tracking outcomes across physical, emotional, spiritual, and social dimensions. Over 350 grant recipients completed assessments.

6VALOR Coalition (Veteran Alliance for Leadership, Outreach, and Recovery)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

VETS is a founding member of VALOR, a national coalition with Navy SEAL Foundation, Wounded Warrior Project, and Green Beret Foundation united to advance practical veteran health policy and expand research access. Launched September 2025.

vetsolutions.org
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Navy SEAL Foundation is a founding member of VALOR coalition and has supported VETS' advocacy efforts, including AB 1103 in California. Robin King, CEO of Navy SEAL Foundation, issued statements supporting psychedelic research reform.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Green Beret Foundation is a founding member of VALOR coalition alongside VETS, Navy SEAL Foundation, and Wounded Warrior Project. Charlie Iacono, President and CEO, supported AB 1103 passage.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Wounded Warrior Project is a founding member of VALOR coalition working to advance mental health policy and psychedelic research access for veterans.

10Texas Ibogaine Initiative (UTHealth Houston, UT Medical Branch at Galveston, Dell Medical School)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Texas committed $100 million (public and private) for ibogaine research led by UTHealth Houston and UT Medical Branch at Galveston with support from Dell Medical School at UT Austin. VETS played central role in securing this funding.

vetsolutions.org
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Logan Davidson serves as both VETS Legislative Director and Executive Director of Texans for Greater Mental Health, advancing psychedelic research policy at state level.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Eliza Dushku serves as Behavioral Health Therapist and Program Development Specialist in Psychedelic-Assisted Psychotherapy at Home Base. Home Base is dedicated to healing the invisible wounds of war for veterans, service members, and military families.

Strategic tierMinorTypeOthers
Description

Production company for In Waves and War documentary by award-winning filmmakers Jon Shenk and Bonni Cohen.

Strategic tierMinorTypeOthers
Description

Participant Media produced In Waves and War documentary, bringing veteran mental health story to global Netflix audience.

15Congressman Dan Crenshaw
Strategic tierMinorTypeOthers
Description

Texas Congressman who worked with VETS to secure psychedelic research funding in the National Defense Authorization Act.

vetsolutions.org
Strategic tierMinorTypeOthers
Description

Co-led by former Energy Secretary Rick Perry. W. Bryan Hubbard is CEO and keynote speaker at VETS events. VETS mentioned as veterans' advocacy group alongside Americans for Ibogaine in White House executive order coverage.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

VALOR coalition co-founder supporting Special Operations veterans and their families; shares the elite-veteran constituency and policy advocacy focus with VETS.

TypeDirect peer
Description

The largest US veteran-focused nonprofit addressing PTSD, TBI, and mental health. Direct peer and VALOR coalition co-founding partner with overlapping mental-health mission and donor base.

TypeDirect peer
Description

Leading psychedelic-research nonprofit that drove FDA review of MDMA-assisted therapy. Closest analog to VETS in the psychedelic policy/research ecosystem and a likely collaborator as the veteran-use case scales.

TypeDirect peer
Description

Nonprofit funding psychedelic therapy access for veterans and first responders. Closely overlapping program model (treatment-access grants abroad) and target population.

TypeDirect peer
Description

Advocacy organization co-led by former Energy Secretary Rick Perry pushing ibogaine research and access; explicitly partnered with VETS on the White House executive order.

TypeDirect peer
Description

VALOR coalition co-founder funding Special Forces veteran health and welfare. Operates in the same donor and beneficiary ecosystem as VETS.

TypeBroad incumbent
Description

Large, established post-9/11 veteran advocacy organization addressing mental health, suicide, and VA policy. Broader in scope but overlapping on policy advocacy and donor base.

TypeEmerging player
Description

Nonprofit funding ibogaine and psychedelic-assisted therapy access; overlaps with VETS' grant model and uses REID Foundation funding, an existing VETS partner.

9Home Base (Red Sox Foundation & Massachusetts General Hospital)
TypeDirect peer
Description

Clinical veteran/family mental health program with an active psychedelic-assisted therapy track where VETS board member Eliza Dushku practices. Peer on treatment delivery and research integration.

TypeDirect peer
Description

Veteran suicide prevention nonprofit with a similar mission footprint (suicide crisis focus) and overlapping donor base, though without the psychedelic-treatment emphasis.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

VETS, Veterans Exploring Treatment Solutions

Veteran Mental Health Servicesvetsolutions.org

VETS (Veterans Exploring Treatment Solutions) is a 501(c)(3) nonprofit founded in 2019 that funds U.S. veterans' access to psychedelic-assisted therapies through grants, research partnerships with Stanford and Ohio State, and veteran-focused policy advocacy.

What VETS, Veterans Exploring Treatment Solutions does

VETS (Veterans Exploring Treatment Solutions) is a 501(c)(3) nonprofit founded in 2019 and headquartered in Coronado, California, that facilitates U.S. veteran access to psychedelic-assisted therapies for PTSD, traumatic brain injury, and other service-related conditions. Its core product is the Foundational Healing Grant program, which directly funds veterans to receive treatment at approved international and domestic clinics — by 2025, the program had supported 1,300+ veterans and spouses with 1,200+ grants awarded across 16 states, accompanied by longitudinal wellbeing assessments (350+ data points) used to build an outcomes evidence base.

The organization operates through three program pillars: Resources (grants, an E-Course, and a Foundational Healing Workbook), Research (clinical study partnerships with Stanford — including a Nature Medicine publication on MDMA-assisted therapy — and Ohio State), and Advocacy (federal and state policy work). Strategic research partnerships with major academic medical centers, alongside direct policy engagement, have helped VETS contribute to securing over $124M in public research funding, including a Texas $100M Ibogaine Initiative, California AB 1103, and a White House executive order on ibogaine research. The VALOR Coalition, launched in 2025 with major Veterans Service Organizations, extends this convening role.

VETS is funded through philanthropic donations rather than commercial revenue. In 2025, total fundraising was approximately $6.7M, drawn from individual donors (~$3.3M), foundations (~$1.99M), events (~$737K), and corporate giving (~$681K). The organization holds a 4-star Charity Navigator rating, has received Emmy nominations for the Netflix documentary "In Waves and War" (premiered November 2025), and reports a 100% veteran recommendation rate. Go-to-market is primarily community and VSO-driven rather than paid acquisition, and brand visibility has been materially elevated by media coverage and policy wins during 2025–2026.

VETS, Veterans Exploring Treatment Solutions firmographics

Firmographics
Name
VETS, Veterans Exploring Treatment Solutions
Legal name
VETS, Inc.
Website
https://vetsolutions.org
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
1–10 employees
Short description
VETS (Veterans Exploring Treatment Solutions) is a 501(c)(3) nonprofit founded in 2019 that funds U.S. veterans' access to psychedelic-assisted therapies through grants, research partnerships with Stanford and Ohio State, and veteran-focused policy advocacy.
Ownership category
akta.pro rank

VETS, Veterans Exploring Treatment Solutions industry classification

Industry
Product category
Veteran Mental Health Services
NAICS
Voluntary Health Organizations (813212), Other Grantmaking and Giving Services (813219)
akta.pro primary industry
Behavioral Health & Substance Use Program Funding (Public Health) (HLAJALAI)

Keywords

  • Veteran mental health services
  • Psychedelic-assisted therapy
  • Nonprofit advocacy
  • Veteran suicide prevention
  • Military mental health

Where VETS, Veterans Exploring Treatment Solutions is headquartered

Location

Headquarters

HQ city
San Diego
HQ country
United States
HQ region
North America

Offices2 records

Markets served

VETS, Veterans Exploring Treatment Solutions business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Operations, Personnel, Marketing or Sales, Technology or R&D, Others

Revenue model

  1. Individual Donations: Individual donors contribute to VETS' mission, including major donors, recurring donors, and event attendees. In 2025, individuals contributed $3.3M out of total income of $6.7M.
  2. Foundation Grants: Foundation funding supports research, advocacy, and program operations. In 2025, foundations contributed $1.99M.
  3. Corporate Partnerships: Corporate sponsors support VETS events and programs, including Black Rifle Coffee Company, Ambio Life Sciences, Dr. Bronner's, and others. In 2025, corporations contributed $681K.
  4. Events: The annual Torchbearer Ball and other fundraising events generate revenue. The 2025 Torchbearer Ball raised over $1.4 million.
  5. Merchandise Sales: VETS operates an online store selling merchandise including the Foundational Healing Workbook and branded items.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels8 records

VETS, Veterans Exploring Treatment Solutions product offering

Product offering

Core offering

VETS provides grant funding and wraparound support to help U.S. military veterans and their spouses access psychedelic-assisted therapies (ibogaine, ketamine, psilocybin, MDMA, 5-MeO-DMT) at vetted third-party international facilities, where these treatments are legal or unregulated. The organization supplements grant funding with preparation and integration coaching, meditation, yoga, and community resources. VETS also funds research (Stanford, Ohio State, UCSF) and drives policy advocacy (Texas Ibogaine Initiative, California AB 1103, federal executive orders) to expand domestic access.

Product overview

VETS (Veterans Exploring Treatment Solutions) is a 501(c)(3) nonprofit organization offering a holistic ecosystem of programs supporting veterans' access to psychedelic-assisted therapies. The core offering is the Foundational Healing Grants program, which provides funding and wraparound support for veterans to access treatments including ibogaine, ketamine, psilocybin, MDMA, and 5-MeO-DMT at international facilities. This is supplemented by the free VETS E-Course for education, the VETS Community Platform for ongoing integration support, the VETS Foundational Healing Workbook for preparation, and Meditation and Breathing Exercises for wellness. The organization also produces advocacy content including the Netflix documentary 'In Waves and War' and hosts the annual Torchbearer Ball fundraising event. All services are designed to address the veteran suicide epidemic through three pillars: resources (direct support), research (scientific validation), and advocacy (policy change).

Differentiator

Problem solved

Functional benefit

Products and services

  • Foundational Healing Grants Grant program that funds U.S. military veterans and their spouses to access psychedelic-assisted therapies (ibogaine, ketamine, psilocybin, MDMA, 5-MeO-DMT) at vetted international facilities, paired with preparation and integration coaching, meditation, yoga, and community resources.
  • VETS Foundational Healing Workbook

Quantifiable outcome

  • 93.2% of polled VETS grant recipients feel less depressed after treatment
  • +4 more outcomes

Companies that use VETS, Veterans Exploring Treatment Solutions

Customer profile

Named customers6 records

Segments4 records

Ideal customer profiles2 records

VETS, Veterans Exploring Treatment Solutions technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

VETS, Veterans Exploring Treatment Solutions partnerships and signals

Strategic signal

Partnerships

16 partnerships are on record, tiered core and minor.

  • Stanford Brain Stimulation LabcoreStrategic or Co-development Partner · 5 January 2024VETS collaborated with Stanford Brain Stimulation Lab led by Dr. Nolan Williams on a groundbreaking Nature Medicine study examining ibogaine therapy effects on veterans with TBI and PTSD. The study enrolled 30 U.S. Special Operations veterans, all supported by VETS through Foundational Healing Grants. Results showed dramatic improvements including reduced suicidal ideation from 47% to 7%.
  • Ambio Life SciencescoreStrategic or Co-development Partner · 5 January 2024All study participants received treatment at Ambio Life Sciences, an independent clinic in Mexico providing somatic therapies alongside psychedelic therapies in a medically supported environment. VETS provided travel funding as part of its grants program.
  • Jonathan Dickinson (Ambio CEO)minorOthers · 5 January 2024Jonathan Dickinson, CEO of Ambio Life Sciences, provided statement reinforcing the safety and efficacy findings from the Stanford study and highlighting ibogaine's healing potential.
  • Ohio State University Center for Psychedelic Drug Research and Education (CPDRE)coreStrategic or Co-development PartnerDr. Alan Davis leads a program evaluation of VETS grant recipients - the largest longitudinal observational study of psychedelic treatment in U.S. veterans with over 130 participants enrolled. Five peer-reviewed publications are in development. The study follows Dr. Davis' 2019 retrospective study of veterans receiving ibogaine therapy.
  • UCSF Translational Psychedelic Research ProgramcoreStrategic or Co-development PartnerFormal collaboration with UCSF's Translational Psychedelic Research Program on wellbeing assessments tracking outcomes across physical, emotional, spiritual, and social dimensions. Over 350 grant recipients completed assessments.
  • VALOR Coalition (Veteran Alliance for Leadership, Outreach, and Recovery)coreStrategic or Co-development PartnerVETS is a founding member of VALOR, a national coalition with Navy SEAL Foundation, Wounded Warrior Project, and Green Beret Foundation united to advance practical veteran health policy and expand research access. Launched September 2025.
  • Navy SEAL FoundationcoreStrategic or Co-development PartnerNavy SEAL Foundation is a founding member of VALOR coalition and has supported VETS' advocacy efforts, including AB 1103 in California. Robin King, CEO of Navy SEAL Foundation, issued statements supporting psychedelic research reform.
  • Green Beret FoundationcoreStrategic or Co-development PartnerGreen Beret Foundation is a founding member of VALOR coalition alongside VETS, Navy SEAL Foundation, and Wounded Warrior Project. Charlie Iacono, President and CEO, supported AB 1103 passage.
  • Wounded Warrior ProjectcoreStrategic or Co-development PartnerWounded Warrior Project is a founding member of VALOR coalition working to advance mental health policy and psychedelic research access for veterans.
  • Texas Ibogaine Initiative (UTHealth Houston, UT Medical Branch at Galveston, Dell Medical School)coreStrategic or Co-development PartnerTexas committed $100 million (public and private) for ibogaine research led by UTHealth Houston and UT Medical Branch at Galveston with support from Dell Medical School at UT Austin. VETS played central role in securing this funding.
  • Texans for Greater Mental HealthminorStrategic or Co-development PartnerLogan Davidson serves as both VETS Legislative Director and Executive Director of Texans for Greater Mental Health, advancing psychedelic research policy at state level.
  • Home Base (Red Sox Foundation and Massachusetts General Hospital)coreStrategic or Co-development PartnerEliza Dushku serves as Behavioral Health Therapist and Program Development Specialist in Psychedelic-Assisted Psychotherapy at Home Base. Home Base is dedicated to healing the invisible wounds of war for veterans, service members, and military families.
  • Actual FilmsminorOthersProduction company for In Waves and War documentary by award-winning filmmakers Jon Shenk and Bonni Cohen.
  • Participant MediaminorOthersParticipant Media produced In Waves and War documentary, bringing veteran mental health story to global Netflix audience.
  • Congressman Dan CrenshawminorOthersTexas Congressman who worked with VETS to secure psychedelic research funding in the National Defense Authorization Act.
  • Americans for IbogaineminorOthersCo-led by former Energy Secretary Rick Perry. W. Bryan Hubbard is CEO and keynote speaker at VETS events. VETS mentioned as veterans' advocacy group alongside Americans for Ibogaine in White House executive order coverage.

Scale indicators22 records

Recent moves6 records

Expansion highlights6 records

VETS, Veterans Exploring Treatment Solutions competitors and assessment

Company assessment

Direct peers

  • Navy SEAL Foundation: VALOR coalition co-founder supporting Special Operations veterans and their families; shares the elite-veteran constituency and policy advocacy focus with VETS.
  • Wounded Warrior Project: The largest US veteran-focused nonprofit addressing PTSD, TBI, and mental health. Direct peer and VALOR coalition co-founding partner with overlapping mental-health mission and donor base.
  • Multidisciplinary Association for Psychedelic Studies (MAPS): Leading psychedelic-research nonprofit that drove FDA review of MDMA-assisted therapy. Closest analog to VETS in the psychedelic policy/research ecosystem and a likely collaborator as the veteran-use case scales.
  • Heroic Hearts Project: Nonprofit funding psychedelic therapy access for veterans and first responders. Closely overlapping program model (treatment-access grants abroad) and target population.
  • Americans for Ibogaine: Advocacy organization co-led by former Energy Secretary Rick Perry pushing ibogaine research and access; explicitly partnered with VETS on the White House executive order.
  • Green Beret Foundation: VALOR coalition co-founder funding Special Forces veteran health and welfare. Operates in the same donor and beneficiary ecosystem as VETS.
  • Home Base (Red Sox Foundation & Massachusetts General Hospital): Clinical veteran/family mental health program with an active psychedelic-assisted therapy track where VETS board member Eliza Dushku practices. Peer on treatment delivery and research integration.
  • Stop Soldier Suicide: Veteran suicide prevention nonprofit with a similar mission footprint (suicide crisis focus) and overlapping donor base, though without the psychedelic-treatment emphasis.

Broad incumbents

Emerging players

  • Reason for Hope Foundation: Nonprofit funding ibogaine and psychedelic-assisted therapy access; overlaps with VETS' grant model and uses REID Foundation funding, an existing VETS partner.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

VETS, Veterans Exploring Treatment Solutions social profiles

Digital presence

VETS, Veterans Exploring Treatment Solutions compliance and trust

Trust signal

Compliance4 records

VETS, Veterans Exploring Treatment Solutions financial estimates

Financial estimate

Revenue estimate

Valuation estimate

VETS, Veterans Exploring Treatment Solutions leadership team

Management profile

Number of profiles

Profiles7 records

VETS, Veterans Exploring Treatment Solutions funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

VETS, Veterans Exploring Treatment Solutions M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about VETS, Veterans Exploring Treatment Solutions

What does VETS, Veterans Exploring Treatment Solutions do?

VETS provides grant funding and wraparound support to help U.S. military veterans and their spouses access psychedelic-assisted therapies (ibogaine, ketamine, psilocybin, MDMA, 5-MeO-DMT) at vetted third-party international facilities, where these treatments are legal or unregulated. The organization supplements grant funding with preparation and integration coaching, meditation, yoga, and community resources. VETS also funds research (Stanford, Ohio State, UCSF) and drives policy advocacy (Texas Ibogaine Initiative, California AB 1103, federal executive orders) to expand domestic access.

Is VETS, Veterans Exploring Treatment Solutions a public or private company?

VETS, Veterans Exploring Treatment Solutions is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was VETS, Veterans Exploring Treatment Solutions founded?

VETS, Veterans Exploring Treatment Solutions was founded in 2019. It employs 1 to 10 people.

Where is VETS, Veterans Exploring Treatment Solutions based?

VETS, Veterans Exploring Treatment Solutions is headquartered in San Diego, United States, in the North America region.

How does VETS, Veterans Exploring Treatment Solutions make money?

Five revenue lines are on record. Individual Donations are the primary driver. The others are foundation Grants, corporate Partnerships, events and merchandise Sales.

Who are VETS, Veterans Exploring Treatment Solutions's main competitors?

Direct peers on record are Navy SEAL Foundation, Wounded Warrior Project, Multidisciplinary Association for Psychedelic Studies (MAPS), Heroic Hearts Project, Americans for Ibogaine, Green Beret Foundation, Home Base (Red Sox Foundation & Massachusetts General Hospital) and Stop Soldier Suicide. Iraq and Afghanistan Veterans of America (IAVA) is listed as a broad incumbent. Reason for Hope Foundation is listed as an emerging player.

Does VETS, Veterans Exploring Treatment Solutions have an API?

No public API is recorded for VETS, Veterans Exploring Treatment Solutions.

What industry is VETS, Veterans Exploring Treatment Solutions in?

VETS, Veterans Exploring Treatment Solutions's product category is Veteran Mental Health Services. Its primary akta.pro industry code is HLAJALAI, Behavioral Health & Substance Use Program Funding (Public Health). Its NAICS code is 813212.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PrwebVETS Ibogaine Grant Recipients Participate in New Research on Magnesium-Ibogaine and Blast TBIVeterans Exploring Treatment Solutions (VETS) highlighted a March 2026 publication in iScience showing increased cortical thickness and decreased predicted brain age in Special Operations veterans with blast-related traumatic brain injury who received a magnesium-ibogaine protocol. This new neuroimaging analysis builds on the same Stanford Brain Stimulation Lab dataset that produced the January 2024 Nature Medicine paper reporting clinical improvements in functioning, PTSD, depression, anxiety, and cognition among 30 male Special Operations veterans. VETS states this reflects its commitment to expanding access to psychedelic-assisted therapies for veterans and advancing related research and policy change.PrwebVeterans Exploring Treatment Solutions (VETS) Applauds White House Executive Order Advancing Ibogaine Research, Urges Accelerated Scientific InvestmentVeterans Exploring Treatment Solutions (VETS) applauded a White House executive order signed on Saturday directing expanded federal attention and potential funding for research into psychedelic compounds including ibogaine for treating post-traumatic stress disorder, traumatic brain injury, and addiction. VETS Co-Founders Amber and Marcus Capone were present at the White House signing, highlighting veterans' role in bringing ibogaine into national policy conversations. The executive order represents a shift in federal engagement with psychedelic medicine research.VetsolutionsVeterans Exploring Treatment Solutions (VETS) Applauds White …Veterans Exploring Treatment Solutions (VETS) applauded a White House executive order signed Saturday directing expanded federal attention and potential funding for research into psychedelic compounds, including ibogaine, for treating veterans' PTSD, TBI, and addiction. VETS has supported approximately 1,300 veterans and spouses since 2019 and collaborated with Stanford on studies showing significant clinical improvements including suicidal ideation dropping from 47% to 7%, with recent Cell research identifying measurable neuroplasticity changes including reduced predicted brain age. The organization has helped secure over $124 million in public funding for psychedelic research and played a central role in the Texas Ibogaine Initiative, the largest public investment in psychedelic research in U.S. history.UsnewsTrump Set to Ease Restrictions on Psychedelic Drug Used to Treat PTSDU.S. President Donald Trump is preparing to order the federal government to reevaluate restrictions on ibogaine, a Schedule I psychedelic drug sometimes used internationally to treat PTSD and other mental health conditions, according to three people familiar with the matter. The executive order, expected as soon as Saturday, would remove barriers to medical research and compassionate use cases, though full reclassification is not expected to substantially alter the substance's legal status in the near term. Veterans' advocacy groups including Veterans Exploring Treatment Solutions and Americans for Ibogaine, co-led by former Energy Secretary Rick Perry, have pushed for ibogaine access citing promising research including a 2025 Stanford study showing improved brain function and reduced PTSD symptoms.PrwebVeterans Exploring Treatment Solutions Applauds Texas Leadership on Ibogaine ResearchLt. Gov. Dan Patrick and House Speaker Dustin Burrows announced that Texas will fully fund a $100 million ibogaine research program in partnership with the state's leading medical research institutions to treat veterans suffering from PTSD and traumatic brain injury. Veterans Exploring Treatment Solutions (VETS), an advocacy organization co-founded by Marcus Capone, issued a statement praising the commitment as a defining moment for veteran healthcare. The initiative positions Texas as a potential national leader in psychedelic-assisted therapy research for military veterans.PrwebVETS Co-Founder & CEO Amber Capone Named to Inc.'s 2026 Female Founders 500 List for Second Consecutive YearAmber Capone, co-founder and CEO of Veterans Exploring Treatment Solutions (VETS), has been named to Inc.'s 2026 Female Founders 500 List for the second consecutive year, recognizing her leadership in advancing veteran mental health care solutions. The selection was made by Inc.'s editorial team following a review of thousands of nominees and highlights founders whose bold ideas and execution create lasting social impact. The recognition follows a year of major policy victories, expanded research funding, and growing national influence for VETS in addressing the veteran suicide epidemic.